Taylor, W., Olupot-Olupot, P., Onyamboko, M., Peerawaranun, P., Weere, W., Namayanja, C., . . . Day, N. (2022). Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: A randomised, double-blind, placebo-controlled, non-inferiority trial. Elsevier.
Cytowanie według stylu Chicago (wyd. 17)Taylor, WR, et al. Safety of Age-dosed, Single Low-dose Primaquine in Children with Glucose-6-phosphate Dehydrogenase Deficiency Who Are Infected with Plasmodium Falciparum in Uganda and the Democratic Republic of the Congo: A Randomised, Double-blind, Placebo-controlled, Non-inferiority Trial. Elsevier, 2022.
Cytowanie według stylu MLA (wyd. 9)Taylor, WR, et al. Safety of Age-dosed, Single Low-dose Primaquine in Children with Glucose-6-phosphate Dehydrogenase Deficiency Who Are Infected with Plasmodium Falciparum in Uganda and the Democratic Republic of the Congo: A Randomised, Double-blind, Placebo-controlled, Non-inferiority Trial. Elsevier, 2022.